Novartis AG (NVS)
94.37
+1.80
(+1.94%)
USD |
NYSE |
Apr 19, 16:00
94.36
-0.02
(-0.02%)
After-Hours: 20:00
Novartis Cash from Investing (Quarterly): -1.76B for Dec. 31, 2023
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -1.76B |
| September 30, 2023 | -2.212B |
| June 30, 2023 | -1.053B |
| March 31, 2023 | 10.62B |
| December 31, 2022 | -1.467B |
| September 30, 2022 | 5.198B |
| June 30, 2022 | -11.63B |
| March 31, 2022 | 9.365B |
| December 31, 2021 | 4.563B |
| September 30, 2021 | -1.232B |
| June 30, 2021 | 97.00M |
| March 31, 2021 | 780.00M |
| December 31, 2020 | -571.00M |
| September 30, 2020 | -2.045B |
| June 30, 2020 | -425.00M |
| March 31, 2020 | -10.14B |
| December 31, 2019 | 318.00M |
| September 30, 2019 | -3.398B |
| June 30, 2019 | -474.00M |
| March 31, 2019 | 1.328B |
| December 31, 2018 | -4.935B |
| September 30, 2018 | -886.00M |
| June 30, 2018 | 4.325B |
| March 31, 2018 | -4.095B |
| December 31, 2017 | -996.00M |
| Date | Value |
|---|---|
| September 30, 2017 | -685.00M |
| June 30, 2017 | -337.00M |
| March 31, 2017 | -1.101B |
| December 31, 2016 | -1.073B |
| September 30, 2016 | -752.00M |
| June 30, 2016 | -844.00M |
| March 31, 2016 | -772.00M |
| December 31, 2015 | -1.69B |
| September 30, 2015 | -753.00M |
| June 30, 2015 | -1.784B |
| March 31, 2015 | -6.557B |
| December 31, 2014 | -919.00M |
| September 30, 2014 | 54.00M |
| June 30, 2014 | -1.077B |
| March 31, 2014 | 2.823B |
| December 31, 2013 | -2.655B |
| September 30, 2013 | -753.00M |
| June 30, 2013 | -640.00M |
| March 31, 2013 | 696.00M |
| December 31, 2012 | -2.536B |
| September 30, 2012 | -1.971B |
| June 30, 2012 | -723.00M |
| March 31, 2012 | -445.00M |
| December 31, 2011 | -824.00M |
| September 30, 2011 | -569.00M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-11.63B
Minimum
Jun 2022
10.62B
Maximum
Mar 2023
-287.58M
Average
-571.00M
Median
Dec 2020
Cash from Investing (Quarterly) Benchmarks
| Sandoz Group AG | -- |
| Amgen Inc | -27.09B |
| AstraZeneca PLC | -1.077B |
| Incyte Corp | -154.50M |
| MorphoSys AG | -- |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 2.547B |
| Cash from Financing (Quarterly) | -607.00M |
| Free Cash Flow | 11.70B |
| Free Cash Flow Per Share (Quarterly) | 0.8505 |
| Free Cash Flow to Equity (Quarterly) | 770.00M |
| Free Cash Flow to Firm (Quarterly) | 1.764B |
| Free Cash Flow Yield | 5.93% |